A joint Roche & FibriCheck team explored how digital solutions such as the FibriCheck app can add value in the AF patient journey, e.g. screening for undiagnosed atrial fibrillation patients.
Roche has collaborated with Lark Health on the pilot study “Cardiac Self-Efficacy Improvement in a Digital Health Pilot Program for Heart Health” to help patients prevent and manage heart disease by targeting Cardiovascular Disease risk factors.
Roche has collaborated with STARTUP CREASHERE to identify partners for a digital platform for HCPs at the PoC to improve workflows and change healthcare in favour of cost efficiency and better patient care.
SagivTech, is a company specializing in artificial intelligence (AI), image processing, and computer vision, founded in 2009 by Chen Sagiv and Nizan Sagiv in Israel.
At Plug and Play, we are excited about our strong global partnership with Roche and our joint mission to transform healthcare together. For the most recent 3 month program (Batch 8), Roche business units have been collaborating with Cerascreen, Decentriq, MediBioSense, Neurotrack, and PxHealthcare.
Type 2 Diabetes has traditionally been considered to be a lifelong condition where one can only hope for better blood sugar control. But modern-age diabetes care and treatment is challenging this long held belief, especially for those who are newly diagnosed with diabetes.
Oncoustics, based in Toronto, Canada, offers an AI solution that analyses raw ultrasound data to provide a quantitative score supporting the detection of diseases including liver and prostate cancer.
Berlin-based startup LabTwin launched the first voice-powered lab assistant in 2019.
Respiree from Singapore provides targeted predictions and diagnosis of cardio-respiratory diseases using a combination of advanced breath-cardio sensors and artificial intelligence.
Us.ai (former eko.ai) from Singapore wants to automate the fight against cardiovascular diseases with their solution that uses machine learning to automate the analysis of echocardiograms.
